Skip to Content

M BE9 (Budesonide Extended-Release 9 mg)

Pill with imprint M BE9 is White, Round and has been identified as Budesonide Extended-Release 9 mg. It is supplied by Mylan Pharmaceuticals Inc..

Budesonide is used in the treatment of crohn's disease; asthma, maintenance; crohn's disease, acute; inflammatory bowel disease; crohn's disease, maintenance and belongs to the drug classes glucocorticoids, inhaled corticosteroids. Risk cannot be ruled out during pregnancy. Budesonide 9 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M BE9

Budesonide extended-release 9 mg M BE9

Budesonide Extended-Release

Imprint
M BE9
Strength
9 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Glucocorticoids, Inhaled corticosteroids
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-4500

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.